ExodusPoint Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-18,843
| Closed | -$2.49M | – | 2090 |
|
|
2025
Q1 | $2.49M | Buy |
18,843
+4,604
| +32% | +$574K | 0.02% | 623 |
|
|
2024
Q4 | $1.19M | Buy |
+14,239
| New | +$1.17M | 0.01% | 893 |
|
|
2024
Q1 | – | Sell |
-11,895
| Closed | -$852K | – | 2053 |
|
|
2023
Q4 | $852K | Sell |
11,895
-16,765
| -58% | -$964K | 0.01% | 868 |
|
|
2023
Q3 | $1.49M | Sell |
28,660
-11,298
| -28% | -$658K | 0.01% | 797 |
|
|
2023
Q2 | $2.53M | Buy |
+39,958
| New | +$2.49M | 0.02% | 712 |
|
|
2021
Q4 | – | Sell |
-6,859
| Closed | -$256K | – | 2689 |
|
|
2021
Q3 | $256K | Buy |
+6,859
| New | +$238K | ﹤0.01% | 1682 |
|
|
2020
Q4 | – | Sell |
-84,027
| Closed | -$2.16M | – | 2467 |
|
|
2020
Q3 | $2.16M | Buy |
+84,027
| New | +$1.92M | 0.04% | 376 |
|
|
2020
Q1 | – | Sell |
-16,490
| Closed | -$566K | – | 1738 |
|
|
2019
Q4 | $566K | Buy |
16,490
+4,108
| +33% | +$49.3K | 0.01% | 795 |
|
|
2019
Q3 | $92K | Buy |
12,382
+1,857
| +18% | +$17.8K | ﹤0.01% | 1243 |
|
|
2019
Q2 | $137K | Buy |
+10,525
| New | +$135K | 0.01% | 988 |
|
Other funds holding ITCI
KIM
HNB